Table 1:

Patient Characteristics of the Biopsy Cohort Compared to a Concurrent Non- biopsy Cohort

	No Biopsy	Biopsy
Number of Patients	1434	382
T Stage:
T1c	541 (38%)	113 (29.6%)
T2	655 (47%)	203 (53.1 %)
T3	238 (17%)	66 (17.3%)
Gleason:
6 or less	738 (51%)	151 (39.5%)
Greater than 6	696 (49%)	231 (60.5%)
Pretreatment PSA (ng/mL)
10 or less	1009 (70%)	182 (47.6%)
Greater than 10	425 (30%)	200 (52.4%)
Age (years)
≤ 65	409 (29%)	149 (39.0%)
>65	1025 (71%)	233 (61.0%)
Dose
Less than 75.6 Gy	280 (19%)	83 (21.7%)
>= 75.6 Gy	1154 (81%)	299 (78.3%)
Use of ADT
Yes	672 (47%)	185 (48.4)
No	762 (53%)	197 (51.6)